Guggenheim Maintains Buy on Ardent Health, Raises Price Target to $14

Benzinga · 2d ago
Guggenheim analyst Jason Cassorla maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $14.